May. 5 at 8:10 PM
$CARL Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.32 up 78.23% YoY
• Reported revenue of
$16.12M up 58.17% YoY
• Carlsmed raised its full year 2026 revenue guidance to a range of
$72M to
$77M, up from prior guidance of
$70M to
$75M, representing 48% growth at the midpoint over 2025.
